Any thoughts on the HHS report? Looked like a decent enough Q4. And they're expecting top & bottom line growth in 2023 after big numbers in 2022...that's encouraging. Considering how the stock limped into the report, I figured it would bounce to $11+ today. Instead it's dropping below $10. Seems like a bargain, so I'm rebuying a few shares.